Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 25-Aug-23 7:17 PM View:  | Apexigen, Inc. (APGN) | 23-Aug-23 | Disposition | 124,296 | -- | -- | (80%) 155.42K to 31.12K | |
| 25-Aug-23 7:17 PM View: | Apexigen, Inc. (APGN) | 23-Aug-23 | Payment of Exercise | 31,123 | $0.39 | $11,985.50 | (100%) 31.12K to 0 | |
| 23-Jun-23 5:54 PM View: | Apexigen, Inc. (APGN) | 15-Jun-23 | Payment of Exercise | 6,917 | $0.49 | $3,396.94 | (4%) 162.34K to 155.42K | |
| 25-May-23 4:18 PM View: | Apexigen, Inc. (APGN) | 23-May-23 | Grant | 150,000 | -- | -- | 453% 33.08K to 183.08K | |
| 25-May-23 4:18 PM View: | Apexigen, Inc. (APGN) | 23-May-23 | Payment of Exercise | 20,748 | $0.40 | $8,299.20 | (11%) 183.08K to 162.34K | |
| 19-Dec-22 5:49 PM View: | Apexigen, Inc. (APGN) | 15-Dec-22 | Payment of Exercise | 6,916 | $1.06 | $7,330.96 | (17%) 40.0K to 33.08K | |
| 11-Oct-22 4:56 PM View: | Apexigen, Inc. (APGN) | 07-Oct-22 | Grant | 40,000 | -- | -- | 100% 0 to 40.0K | |
| 19-Apr-21 8:04 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 16-Apr-21 | Grant | 66,000 | -- | -- | 62% 105.85K to 171.85K | |
| 19-Apr-21 8:04 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 16-Apr-21 | Disposition | 169,468 | $38.00 | $6,439,780.00 | (99%) 171.85K to 2.38K | |
| 19-Apr-21 8:04 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 16-Apr-21 | Disposition | 2,385 | $38.00 | $90,630.00 | (100%) 2.38K to 0 | |
| 19-Apr-21 8:04 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 06-Apr-21 | Gift | 14,174 | -- | -- | (12%) 119.23K to 105.06K | |
| 19-Apr-21 8:04 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 05-Apr-21 | Gift | 2,460 | -- | -- | (2%) 121.69K to 119.23K | |
| 19-Apr-21 8:04 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 01-Apr-21 | Gift | 2,385 | -- | -- | 2% 123.13K to 125.52K | |
| 19-Apr-21 8:04 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 01-Apr-21 | Gift | 3,825 | -- | -- | (3%) 125.52K to 121.69K | |
| 02-Mar-21 12:16 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 26-Feb-21 | Payment of Exercise | 1,158 | $22.23 | $25,742.30 | (< 1%) 124.59K to 123.43K | (71%) |
| 26-Feb-21 2:42 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 25-Feb-21 | Payment of Exercise | 1,653 | $23.08 | $38,151.20 | (1%) 126.24K to 124.59K | (65%) |
| 26-Feb-21 2:42 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 24-Feb-21 | Payment of Exercise | 5,100 | $25.71 | $131,121.00 | (4%) 131.34K to 126.24K | (48%) |
| 15-Dec-20 12:19 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 11-Dec-20 | Payment of Exercise | 11,583 | $16.14 | $186,950.00 | (8%) 138.01K to 126.43K | (135%) |
| 15-Dec-20 12:19 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 11-Dec-20 | Option Exercise | 22,000 | -- | -- | 19% 116.01K to 138.01K | |
| 13-Nov-20 12:38 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 11-Nov-20 | Payment of Exercise | 11,001 | $18.00 | $198,018.00 | (9%) 127.01K to 116.01K | (111%) |
| 13-Nov-20 12:38 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 11-Nov-20 | Option Exercise | 22,000 | -- | -- | 21% 105.01K to 127.01K | |
| 26-Feb-20 8:29 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 26-Feb-20 | Payment of Exercise | 1,304 | $4.83 | $6,298.32 | (1%) 106.31K to 105.01K | (684%) |
| 26-Feb-20 8:29 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 25-Feb-20 | Payment of Exercise | 1,863 | $4.87 | $9,072.81 | (2%) 108.18K to 106.31K | (678%) |
| 26-Feb-20 8:29 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 24-Feb-20 | Grant | 30,000 | -- | -- | 38% 78.18K to 108.18K | |
| 06-Feb-20 6:49 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 05-Feb-20 | Payment of Exercise | 4,070 | $5.13 | $20,879.10 | (5%) 82.25K to 78.18K | (639%) |
| 04-Sep-19 1:15 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 01-Sep-19 | Payment of Exercise | 2,811 | $5.43 | $15,263.70 | (3%) 85.06K to 82.25K | (598%) |
| 27-Feb-19 7:53 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 26-Feb-19 | Payment of Exercise | 1,194 | $11.95 | $14,268.30 | (1%) 84.15K to 82.95K | (217%) |
| 27-Feb-19 7:53 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 25-Feb-19 | Grant | 10,000 | -- | -- | 13% 74.15K to 84.15K | |
| 07-Feb-19 5:24 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 05-Feb-19 | Payment of Exercise | 2,996 | $11.43 | $34,244.30 | (4%) 77.14K to 74.15K | (231%) |
| 02-Oct-18 6:46 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 28-Sep-18 | Grant | 1,923 | -- | -- | 3% 76.18K to 78.1K | |
| 02-Oct-18 6:46 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 28-Sep-18 | Payment of Exercise | 954 | $13.92 | $13,279.70 | (1%) 78.1K to 77.14K | (172%) |
| 05-Sep-18 11:27 AM View: | Five Prime Therapeutics, Inc. (FPRX) | 01-Sep-18 | Payment of Exercise | 2,810 | $14.00 | $39,340.00 | (4%) 78.99K to 76.18K | (171%) |
| 28-Feb-18 7:15 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 26-Feb-18 | Grant | 7,000 | -- | -- | 10% 71.99K to 78.99K | |
| 03-Mar-17 1:33 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 01-Mar-17 | Payment of Exercise | 19,784 | $44.77 | $885,730.00 | (21%) 94.9K to 75.12K | 15% |
| 07-Sep-17 12:03 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 01-Mar-17 | Payment of Exercise | 3,131 | $34.34 | $107,519.00 | (4%) 75.12K to 71.99K | |
| 09-Feb-17 7:30 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 07-Feb-17 | Grant | 16,078 | -- | -- | 20% 78.82K to 94.9K | |
| 18-Jan-17 8:31 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 18-Jan-17 | Option Exercise | 3,636 | $5.54 | $20,143.40 | 5% 78.82K to 82.46K | |
| 18-Jan-17 8:31 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 18-Jan-17 | Market Option Sale (Planned) | 3,636 | $47.39 | $172,310.00 | (4%) 82.46K to 78.82K | 20% |
| 05-Jan-17 2:24 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 03-Jan-17 | Payment of Exercise | 2,442 | $48.60 | $118,681.00 | (3%) 81.27K to 78.82K | 22% |
| 30-Nov-16 11:54 AM View: | Five Prime Therapeutics, Inc. (FPRX) | 28-Nov-16 | Option Exercise | 1,710 | $5.54 | $9,473.40 | 2% 81.27K to 82.98K | |
| 30-Nov-16 11:54 AM View: | Five Prime Therapeutics, Inc. (FPRX) | 28-Nov-16 | Market Option Sale (Planned) | 1,710 | $60.14 | $102,839.00 | (2%) 82.98K to 81.27K | 37% |
| 28-Nov-16 7:40 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 25-Nov-16 | Option Exercise | 21,189 | $6.24 | $132,136.00 | 26% 81.27K to 102.45K | |
| 28-Nov-16 7:40 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 25-Nov-16 | Market Option Sale (Planned) | 21,189 | $60.48 | $1,281,510.00 | (21%) 102.45K to 81.27K | 37% |
| 28-Nov-16 7:40 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 23-Nov-16 | Option Exercise | 13,465 | $6.89 | $92,773.90 | 17% 81.27K to 94.73K | |
| 28-Nov-16 7:40 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 23-Nov-16 | Market Option Sale (Planned) | 13,465 | $60.23 | $810,997.00 | (14%) 94.73K to 81.27K | 37% |
| 12-Sep-16 5:55 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 08-Sep-16 | Grant | 7,000 | -- | -- | 9% 74.27K to 81.27K | |
| 01-Sep-16 7:37 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 01-Sep-16 | Payment of Exercise | 19,568 | $44.74 | $875,472.00 | (21%) 93.83K to 74.27K | 15% |
| 29-Aug-16 6:52 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 25-Aug-16 | Grant | 10,000 | -- | -- | 12% 83.83K to 93.83K | |
| 31-Mar-16 6:40 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 30-Mar-16 | Option Exercise | 5,550 | $8.49 | $47,119.50 | 7% 83.83K to 89.38K | |
| 31-Mar-16 6:40 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 30-Mar-16 | Market Option Sale (Planned) | 5,550 | $40.01 | $222,055.00 | (6%) 89.38K to 83.83K | 5% |